Document Detail


Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.
MedLine Citation:
PMID:  20970030     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The most significant long-term complication of radiotherapy in the head-and-neck region is hyposalivation and its related complaints, particularily xerostomia. This review addresses the pathophysiology underlying irradiation damage to salivary gland tissue, the consequences of radiation injury, and issues contributing to the clinical management of salivary gland hypofunction and xerostomia. These include ways to (1) prevent or minimize radiation injury of salivary gland tissue, (2) manage radiation-induced hyposalivation and xerostomia, and (3) restore the function of salivary gland tissue damaged by radiotherapy.
Authors:
Arjan Vissink; James B Mitchell; Bruce J Baum; Kirsten H Limesand; Siri Beier Jensen; Philip C Fox; Linda S Elting; Johannes A Langendijk; Robert P Coppes; Mary E Reyland
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  International journal of radiation oncology, biology, physics     Volume:  78     ISSN:  1879-355X     ISO Abbreviation:  Int. J. Radiat. Oncol. Biol. Phys.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-25     Completed Date:  2010-11-10     Revised Date:  2011-11-21    
Medline Journal Info:
Nlm Unique ID:  7603616     Medline TA:  Int J Radiat Oncol Biol Phys     Country:  United States    
Other Details:
Languages:  eng     Pagination:  983-91     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Affiliation:
Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Grongingen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Gene Therapy / methods
Head and Neck Neoplasms / radiotherapy*
Humans
Radiation Injuries / prevention & control*
Radiation-Protective Agents / therapeutic use
Radiotherapy / methods,  trends
Saliva, Artificial / therapeutic use
Salivary Glands / radiation effects*
Stem Cell Transplantation / methods
Xerostomia / etiology,  prevention & control,  therapy*
Grant Support
ID/Acronym/Agency:
R01 DE015648-08/DE/NIDCR NIH HHS; R13 DE19330/DE/NIDCR NIH HHS
Chemical
Reg. No./Substance:
0/Radiation-Protective Agents; 0/Saliva, Artificial

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of ac...
Next Document:  Validity of the graded prognostic assessment-derived index to predict brain-metastatic patients' sur...